Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To determine the objective response rate of entrectinib, as assessed by BICR, in each patient population basket of solid tumors that harbor an NTRK1/2/3, ROS1, or ALK gene rearrangement
Inclusion criteria
- Locally Advanced or Metastatic Solid Tumors that Harbor NTRK1/2/3, ROS1,
- or ALK Gene Rearrangements